| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 727.10M | 757.10M | 802.50M | 743.60M | 615.80M |
| Gross Profit | 280.80M | 109.30M | 108.10M | 269.70M | 225.70M |
| EBITDA | 179.80M | 124.00M | 201.70M | 186.60M | 167.70M |
| Net Income | 54.90M | 20.00M | 85.60M | 73.70M | 59.50M |
Balance Sheet | |||||
| Total Assets | 1.05B | 1.07B | 1.14B | 1.17B | 1.07B |
| Cash, Cash Equivalents and Short-Term Investments | 25.20M | 19.10M | 45.20M | 37.20M | 39.30M |
| Total Debt | 190.80M | 150.90M | 96.90M | 136.60M | 156.20M |
| Total Liabilities | 411.70M | 397.50M | 344.40M | 385.70M | 384.40M |
| Stockholders Equity | 640.20M | 668.10M | 790.80M | 780.90M | 684.70M |
Cash Flow | |||||
| Free Cash Flow | 58.90M | 82.50M | 109.20M | 70.10M | 87.10M |
| Operating Cash Flow | 135.30M | 152.60M | 191.60M | 137.10M | 139.10M |
| Investing Cash Flow | -56.00M | -112.80M | -71.20M | -62.30M | -104.80M |
| Financing Cash Flow | -71.00M | -67.60M | -110.20M | -82.80M | -30.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £897.40M | 15.43 | 33.12% | 1.01% | 24.42% | 103.25% | |
70 Outperform | £176.33M | 10.69 | 6.13% | 1.02% | 14.49% | 76.33% | |
65 Neutral | £98.26M | 7.63 | 3.83% | 6.69% | -13.30% | -60.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £1.09B | 22.48 | 8.58% | 3.30% | -6.95% | -52.08% | |
62 Neutral | £529.77M | 28.89 | 8.04% | 4.87% | -7.30% | -59.71% | |
61 Neutral | £4.88B | 30.76 | 13.86% | 2.46% | 0.10% | -15.33% |